Skip to main content

Advertisement

Table 2 Mortality in IgA anti-tTG positive individuals based on follow-up timea

From: Increased mortality among men aged 50 years old or above with elevated IgA anti-transglutaminase antibodies: NHANES III

Follow-up tTGA+ Deaths tTGA- Deaths Adjusted HR; 95 % CI P value Absolute risk/1000 PYAR Excess risk/1000 PYAR
All 58 2996 1.43; 1.10–1.85 0.007 74 22
Year <1 8 134 3.52; 1.72–7.20 0.001 100 72
1–4.99 19 778 1.58; 1.00–2.49 0.051 70 26
5+ 31 2084 1.18; 0.83–1.69 0.354 71 11
  1. Reference is general population comparator cohort
  2. tTGA tissue transglutaminase antibody, PYAR Person-years at risk
  3. aAll hazard ratios (HRs) were adjusted for sex, race, age, and ever smoking. See text for additional explanation